Propanc Biopharma, Inc. (PPCB): Total Assets
$12.78M
As of 2026-06-30
$10.33M
As of 2026-09-30
n/m
3-year compound annual growth
n/m
5-year compound annual growth
+42.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | $12.78M | -34.9% | 2026-09-25, Balance as of period end |
| 2025-06-30 | $19.63M | n/m | 2026-09-25, Balance as of period end |
| 2024-06-30 | $72.4K | +20.0% | 2025-09-29, Balance as of period end |
| 2023-06-30 | $60.3K | -26.1% | 2024-09-30, Balance as of period end |
| 2022-06-30 | $81.7K | +523.2% | 2023-09-28, Balance as of period end |
| 2021-06-30 | $13.1K | -86.7% | 2022-09-28, Balance as of period end |
| 2020-06-30 | $98.5K | -3.1% | 2021-09-28, Balance as of period end |
| 2019-06-30 | $101.7K | +42.4% | 2020-10-01, Balance as of period end |
| 2018-06-30 | $71.4K | -24.9% | 2019-10-15, Balance as of period end |
| 2017-06-30 | $95.1K | -74.9% | 2018-09-17, Balance as of period end |
| 2016-06-30 | $379.1K | -39.5% | 2017-09-28, Balance as of period end |
| 2015-06-30 | $627.1K | +451.3% | 2016-09-28, Balance as of period end |
| 2014-06-30 | $113.7K | n/m | 2015-09-30, Balance as of period end |
| 2013-06-30 | $1.7K | -96.2% | 2014-10-14, Balance as of period end |
| 2012-06-30 | $46.3K | -99.6% | 2013-10-15, Balance as of period end |
| 2011-06-30 | $10.81M | n/a | 2012-10-15, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | $12.78M | -34.9% |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | $12.73M | n/m |
| PMGC Holdings Inc. (ELAB) | 2025-12-31 | $12.87M | +43.1% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $12.96M | +254.9% |
| Imunon, Inc. (IMNN) | 2025-12-31 | $12.29M | +26.5% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $12.16M | +493.6% |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | $13.53M | +254.8% |
| CalciMedica, Inc. (CALC) | 2025-12-31 | $13.59M | -31.3% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $12.00M | +165.1% |
Compare PPCB, NMAD, ELAB, NRXP side by side · Screen every company in Pharmaceutical Preparations ↗